Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[18F]F-AraG PET Imaging in HIV
NCT03684655Phase 2Recruiting
- Sponsor
- CellSight Technologies
- Start
- Sep 2018
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of [18F]fluoro-arabinofuranosyl guanine in human immunodeficiency virus infection (HIV), sponsored by CellSight Technologies. Started Sep 2018; status: recruiting.
02
Drugs
[18F]fluoro-arabinofuranosyl guanine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT03684655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03684655.